Who founded Vector Biomed?

Vector Biomed was founded by Boro Dropulic in 2021.

Who are Vector Biomed's investors?

Vector Biomed's investors include Viking Global.

How much funding has Vector Biomed raised?

Vector Biomed has disclosed $7.5M raised across 1 round.

Where is Vector Biomed headquartered?

Vector Biomed is headquartered in Gaithersburg, US.

Vector Biomed

Gaithersburg, US · Founded 2021 · Delaware corporation · 1 known investors

Find your way into Vector Biomed

Paths you didn't know you had: your email and LinkedIn already hold routes to the Vector Biomed team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vector Biomed develops lentiviral vectors for cell and gene therapy, focusing on affordable, scalable vector solutions with transparent pricing and no hidden royalties. It positions itself as a manufacturing and development partner for researchers and therapeutic developers.

Advanced Manufacturing Biotech Healthtech Medical Devices

Founders & leadership

Vector Biomed was founded in 2021 by Boro Dropulic.

Boro DropulicFounder · CEOA scientist and manager in the gene-modified cell therapy field who has founded multiple companies. He serves as Executive Officer and Director of Vector Biomed, which develops lentiviral vectors for cell and gene therapy.

James KennyNamed on SEC filing

Peter LeeNamed on SEC filing

Investors · 1

Viking Globallisted by Viking GlobalStamford

How we know: Viking Global's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$7.5M disclosed across 1 round · 2022

▶$7.5MraisedDec 2022 · 3 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

James KennyDirector
Boro DropulicExecutive Officer, Director
Peter LeeDirector

Offering amount: $15M
Amount sold: $7.5M
First sale: Nov 2022
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Vektor MedicalVektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias. Its technology targets electrophysiologists and cardiologists working in cardiac rhythm management.

RevvityRevvity develops and sells reagents, instruments, software, and services for life sciences research and clinical diagnostics, serving pharmaceutical, biotech, academic and government institutions across drug discovery, development, and disease diagnosis workflows.

Companies working in the same space as Vector Biomed.

Frequently asked questions

What does Vector Biomed do?: Vector Biomed develops lentiviral vectors for cell and gene therapy, focusing on affordable, scalable vector solutions with transparent pricing and no hidden royalties. It positions itself as a manufacturing and development partner for researchers and therapeutic developers.
Who founded Vector Biomed?: Vector Biomed was founded by Boro Dropulic in 2021.
Who are Vector Biomed's investors?: Vector Biomed's investors include Viking Global.
How much funding has Vector Biomed raised?: Vector Biomed has disclosed $7.5M raised across 1 round.
Where is Vector Biomed headquartered?: Vector Biomed is headquartered in Gaithersburg, US.